Efficacy and safety of biosimilar rituximab in the treatment of pemphigus vulgaris: a single center experience of 12 cases
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2020.1729955
Abstract: Abstract Objective Rituximab, a chimeric monoclonal antibody that targets the CD-20 molecule on B-cells’ surface, has led to significant advances in the treatment of autoimmune pemphigus in recent decades. The aim of the study was… read more here.
Keywords: safety; rituximab; pemphigus vulgaris; treatment ... See more keywords